Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
Noninvasive Ventilation, Low Birth Weight
About this trial
This is an interventional treatment trial for Noninvasive Ventilation
Eligibility Criteria
Inclusion Criteria:
- < 1501 grams (VLBW (very low birth weight) infant)
- Patient must be receiving daily caffeine therapy for apnea
- On non-invasive ventilation, either NIPPV or non-invasive NAVA
Exclusion Criteria:
- No concerns for acute sepsis (i.e., blood cultures, if drawn, have been negative for 48 hours, and no active signs/symptoms of sepsis).
- No history of meningitis or seizures
- No signs of increased intracranial pressure, including bulging fontaneIle, presence of ventricular shunt device, or ventriculomegaly by most recent ultrasound.
- Presence of Grade III or IV intraventricular hemorrhage
- No cyanotic heart defects or clinically significant congenital heart disease. Will allow PDA (patent ductus arteriosus), PFO (patent foramen ovale), and mild to moderate ASD (atrial septal defect)/VSD (ventricular septal defect) as determined by pediatric cardiology.
- Non -English speaking legal representatives (parents)
Sites / Locations
- Virginia Commonwealth University
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Nasal Intermittent Positive Pressure Ventilation (NIPPV) Mode
Neurally Adjusted Ventilatory Assist (NAVA) Mode
After a one hour stabilization period, during which small adjustments to the noninvasive settings can be made to clinically optimize the settings, the study will begin. A Nellcor pulse oximeter probe will be placed on an extremity to provide a continuous non-invasive downloadable measure of saturation (blood oxygen level) and heart rate. Data from the ventilator will be downloaded in real-time to a laptop. These data will be recorded for 4 hours continuously. After that, the ventilator will be switched to the other mode (NIPPV to NAVA), at the same PEEP (positive end-expiratory pressure) and respiratory rate. One hour will be allowed to adjust the ventilator settings. Data will then be collected for 4 hours on the second ventilation mode (NAVA)
After a one hour stabilization period, during which small adjustments to the noninvasive settings can be made to clinically optimize the settings, the study will begin. A Nellcor pulse oximeter probe will be placed on an extremity to provide a continuous non-invasive downloadable measure of saturation (blood oxygen level) and heart rate. Data from the ventilator will be downloaded in real-time to a laptop. These data will be recorded for 4 hours continuously. After that, the ventilator will be switched to the other mode (NAVA to NIPPV), at the same PEEP and respiratory rate. One hour will be allowed to adjust the ventilator settings. Data will then be collected for 4 hours on the second ventilation mode (NIPPV)